DALLAS, Nov. 6, 2025 /PRNewswire/ -- Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) today announced the addition of Starjemza®, a new biosimilar medication, to its growing portfolio of affordable ...
Avy Punwasee is a Partner at Revenue Management Labs. We help companies develop and execute pricing solutions to maximize profits. Cost-plus pricing has long been a standard method for setting product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback